Table 2. Changes in CK2 gene expression in breast cancer.

Gene	P-Value	Fold Change	Rank (Top %)	Dataset	#Samples	Reference
Ductal Breast Carcinoma
CK2α	7.43 10−11	2	1%	Richardson 2	47	[65]
CK2α'	2.05 10−4	−1.6	3%	Sorlie	85	[66]
	9.15 10−4	−1.6	6%	Sorlie Breast 2	167	[67]
	1.79 10−4	−1.5	10%	Richardson 2	47	[65]
Invasive Ductal Breast Carcinoma
CK2α	8.09 10−28	1.6	4%	TCGA Breast	593	[68]
	2.06 10−70	1.5	4%	Curtis	2136	[69]
CK2α'	4.04 10−20	−1.5	10%	TCGA Breast	593	[68]
	5.39 10−50	−1.5	5%	Curtis	2136	[69]
	1.08 10−4	−1.6	4%	Zhao	64	[70]
CK2β	2.48 10−51	1.4	8%	Curtis	2136	[69]
Lobular Breast Carcinoma
CK2α'	6.37 10−4	−1.5	4%	Zhao	64	[70]
Invasive Lobular Breast Carcinoma
CK2α'	3.75 10−11	−1.6	5%	TCGA Breast	593	[68]
	4.51 10−43	−1.6	3%	Curtis	2136	[69]
CK2β	8.00 10−39	1.4	2%	Curtis	2136	[69]
Mucinous Breast Carcinoma
CK2α	4.33 10−5	1.5	2%	TCGA Breast	593	[68]
	1.39 10−16	1.4	3%	Curtis	2136	[69]
Invasive Mucinous Breast Carcinoma
CK2β	2.48 10−51	1.4	8%	Curtis	2136	[69]
Breast Carcinoma
CK2α'	3.09 10−5	−1.7	8%	Curtis	2136	[69]
Invasive Breast Carcinoma
CK2α	3.58 10−15	1.5	6%	TCGA Breast	593	[68]
Invasive Breast Carcinoma Stroma
CK2α	1.2 10−28	−2.2	2%	Finak Breast	59	[71]
CK2α'	7.45 10−12	−6.8	15%	Finak Breast	59	[71]
CK2β	3.02 10−20	−5.7	7%	Finak Breast	59	[71]
Tubular Breast Carcinoma
CK2α'	3.22 10−36	−1.8	2%	Curtis	2136	[69]
Invasive Medullary Carcinoma
CK2αP	1.2 10−9	1.5	5%	Curtis	2136	[69]
CK2β	1.4 10−10	1.6	4%	Curtis	2136	[69]

Different subtypes of breast cancer are analyzed and p-values, fold changes, and datasets are included.